tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 121 are a BUY (59.9%), 64 are a HOLD (31.68%), 17 are a SELL (8.42%).
Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 68.43% that have a potential upside of 18.03% achieved within 174 days.
Matthew Taylor’s has documented 389 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 17-Jul-2025.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$162
$35.15 (27.71%)
$159
14 days ago
(16-Oct-2025)
18/25 (72%)
$33.46 (26.03%)
499
Buy
$142
$15.15 (11.94%)
$144
15 days ago
(15-Oct-2025)
7/11 (63.64%)
$14.37 (11.26%)
317
Buy
$146
$19.15 (15.10%)
$141
15 days ago
(15-Oct-2025)
18/23 (78.26%)
$18.37 (14.39%)
376
Buy
$145
$18.15 (14.31%)
$137
3 months 13 days ago
(17-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
369
Buy
$145
$18.15 (14.31%)
$139
3 months 13 days ago
(17-Jul-2025)
6/9 (66.67%)
$21.33 (17.25%)
753
Which stock is Matthew Taylor is most bullish on?
What Year was the first public recommendation made by Matthew Taylor?
